NCT06706791View on ClinicalTrials.gov

Effect of Empagliflozin on Quality of Life in Chronic Heart Failure Patients With Diabetes Mellitus Type II

PHASE4RecruitingINTERVENTIONAL

Enrollment

156

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

June 1, 2026

Study Completion Date

December 1, 2026

Conditions

Chronic Heart Failure

Interventions

DRUG

Empagliflozin 10 MG

participants will be divided in two groups one group will empagliflozin 10mg once daily along with standard treatment secong group receiving placebo once daily along with standard treatment.

Trial Locations (1)

75120

RECRUITING

Fazaia Ruth Pfau Hospital, Karachi

All Listed Sponsors

lead

Fazaia Ruth Pfau Medical College

OTHER